The outer membrane compnents of Gram-negative rods and bacterial activity of complement;Struktury zewnȩtrzne bakterii Gram-ujemnych a bakteriobójcza aktymwość dopełniacza

Postepy Mikrobiologii

Volumn 43, Issue 1, 2004, Pages 39-57

  Mielnik, Gabriela ^a   Doroszkiewicz, Włodzimierz ^a   Korzeniowska Kowal, Agnieszka ^b  

^a UNIVERSITY OF WROC AW   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENT; OUTER MEMBRANE PROTEIN; SIALIC ACID;

ARTICLE; BACTERIAL OUTER MEMBRANE; COMPLEMENT ACTIVATION; GRAM NEGATIVE BACTERIUM; HUMAN; LIPID COMPOSITION; MEMBRANE STRUCTURE; NONHUMAN; SERUM BACTERICIDAL ACTIVITY;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 2542425774     PISSN: 00794252     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Adlam C., Knights J.M., Mugridge A., Wiliams J.M., Lindom J.C.: Production of colominic acid by Pasteurella haemolytica serotype A2 organisms. FEMS Microbiol. Lett. 42, 23-25 (1987)
2. Alexander J.W., Alexander S.L., Curtis S.R.: Bactericidal activity of human serum against Escherichia coli x 1776. Infect. Immun. 28, 837-840 (1980)
3. Apicella M.A., Mandrell R.E., Shero M., Wilson M.E., Griffiss J.M., Brooks G.F., Lammel C., Breen J.F., Rice P.A.: Modification by sialic acid of Neisseria gonorrhoeae lipopolysaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J. Inf. Dis. 162, 506-512 (1990)
4. Aspinal G.O., Mc Donald A.G., Raju T.S., Pang H., Mills S.D., Kurjanczyk L.A., Penner J.L.: Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides. J. Bacteriol. 174, 1324-1332 (1999)
5. Barak M., Ulitzur S., Merzbach D.: Determination of serum bactericidal activity with the aid of luminous bacteria. J. Clin. Microbiol. 18, 248-260 (1983)
6. Barry G.T.: Colominic acid, a polymer of N-acetylneuraminic acid. J. Exp. Med. 107, 507-521 (1958)
7. Bavoil P., Nikaido H.: Physical interaction between the phage receptor protein and the carrier immobilized maltose-binding protein of Escherichia coli. J. Biol. Chem. 256, 11385-11388 (1981)
8. Bayer M.E.: Areas of adhesion between wall and membrane of Escherichia coli. J. Gen. Microbiol. 53, 395-404 (1968)
9. Benz R., Janko K., Lauger P.: Ionic selectivity of pores formed by the matrix protein (porin) of Escherichia coli. Bioch. Bioph. Acta, 551, 238-247 (1979)
10. Bhattacharjee A.K., Jennings H.J., Kenny C.P., Martin A., Smith J.C.P.: Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance. J. Biol. Chem. 250, 1926-1932 (1975)
11. Biesma D.H., Hannema A., Velzen-Blad H., Mulder L., Zwiten R., Kluijt I., Roos D.: A family with complement factor D deficiency. J. Clin. Invest. 108, 233-240 (2001)
12. Binns M.M., Davies D.L., Hardy K.G.: Cloned fragments of the plasmid Col V, I-K 94 specifying virulence and serum resistance. Nature, 279, 778-781 (1979)
13. Blake M.S., Gotschlich E.C.: Functional and immunological properties of pathogenic neisserial surface proteins. In. Inouye M. (Ed.) Bacterial Outer Membranes as Model Systems. John Wiley, New York, s. 337-400, 1986
14. Blaser M.J., Smith P.E., Hopkins J.A., Heinzer I., Bryner J.H., Wang W-L.L.: Pathogenesis of Campylobacter fetus Infections: serum resistance associated with hight-molecular-weight surface proteins. J. Infect. Dis. 155, 696-706 (1987)
15. Cross A.S., Kim K.S., Wright D.C., Sadoff J.C., Gemski P.: Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. J. Infect. Dis. 154, 497-499 (1986)
16. Devine D.A., Roberts A.P.: K1, K5 and O-antigen Escherichia coli in relation to serum killing via the classical and alternative complement pathways. J. Med. Microbiol. 41, 139-144 (1994)
17. Ding A., Sanchez Z., Tancinco M., Nathan C.: Interactions of bacterial lipopolysaccharide with microtubule proteins. J. Immunol. 148, 2853-2858 (1992)
18. Doroszkiewicz W., Lachowicz T.M.: Mechanism of antigenic variation in Shigella flexneri bacilli in vivo. I. Selective lethal effect of normal sera on mixed population of Shigella flexneri 1b serotype and its antigenic 3b mutant. Arch. Immunol. Ther. Exp. 37, 195 (1989)
19. Egan W., Liu T.-Y., Dorrow D., Cohen J.S., Robbins J.D., Gotschlich E.C., Robbins J.B.: Structural studies on the sialic acid polysaccharide antigen of Escherichia coli strain Bos-12. Biochemistry. 16, 3687-3692 (1977)
20. Elkins Ch., Morrow K.J., Olsen B.: Serum resistance in Haemophilus ducreyi Requires outer membrane protein DsrA. Infect. Immun. 68, 1608-1619 (2000)
21. Encyklopedia Biologiczna. OPRES. Kraków 1998, s. 13-15, 50-51
22. Estabrook M.M., Griffiss J.M., Jarvis G.A. Sialytion of Neisseria meningitidis lipopooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose. Infect. Immun. 65, 4436-4444 (1997)
23. Franiczek R., Jankowski S.: Współdziałanie cefotaksymu i normalnej surowicy ludzkiej w procesie bakteriobójczym wobec pałeczek Escherichia coli wytwarzaja̧cych powierzchniowy antygen K1. Med. Dośw. Microbiol. 45, 61-64 (1993)
24. Gamian A.: Lipopolisacharydy zawieraja̧ce kwas sjalowy. Post. Hig. Med. Dośw. 50, 459-472 (1996)
25. 1H NMR spectroscopy. Biochemistry, 30, 5032-5038 (1991)
26. Goła̧b J., Stokłosa T.: Mechanizmy unikania odpowiedzi immunologicznej przez bakterie i wirusy. Nowa Klinika (Immunologia), 6, 601-605 (1999)
27. Guerry P., Ewing Ch., Hickey T.E., Prendergast M.M., Moran A.P.: Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacterjejuni. Infect. Immun. 68, 6656-6662 (2000)
28. Hefferman E.J., Reed S., Hackelt J., Fierer J., Roudier C., Guiney D.: Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck. J. Clin. Invest. 90, 953-964 (1992)
29. Hellman J., Loiselle P.M., Tehan M.M., Allaire J.E., Boyle L.A., Kurnick J.T., Andrews D.M., Kim K.S., Warren H.S.: Outer membrane protein A, peptidoglycan-associated lipoprotein and murein lipoprotein are released by Escherichia coli bacteria into serum. Infect. Immun. 68, 2566-2572 (2000)
30. Holst O., Brade H.: Chemical structure of the core region of lipopolysaccharides. Molecular Biochemistry and Cellular Biology, Bacterial Endotoxic Lipopolysaccharides, vol. 1, CRC Press, Boca Raton: FI. s. 135-170, 1992
31. Jack D.L., Dodds A.W., Anwar N., Ison C.A., Law A., Frosch M., Turner M.W., Klein N.J.: Activation of complement by mannose binding lectin on isogenic mutants of Neisseria meningitidis. I. Immunol. 160, 13-1353 (1998)
32. Janas T., Merker R.I., Troy F.A.: Polysialic acid synthesis in neuroinvasive Escherichia coli K1: the functional domain of the polysialyltransferase complex is localized on the citoplasimic surface of the inner membrane. Glycoconj. J. 8, 153-154 (1991)
33. Jankowski S.: Aktywność bakteriobójcza dopełniacza oraz mechanizmy adaptacyjne chronia̧ce bakterie Gram-ujemne przed jego działaniem. Rozprawy habilitacyjne, AM Wrocław (1991)
34. Jankowski S.: Mechanizmy obronne chronia̧ce bakterie Gram-ujemne przed bakteriobójczym działaniem dopełniacza. Post. Mikrobiol. 34, 23-44 (1995)
35. Jankowski S.: Właściwości biologiczne komplementu. II Konf. Nauk. "Zaburzenia odporności wieku rozwojowego". 24-25.04.1997. Wrocław. Materiały Naukowe. s. 7-15
36. Jankowski S., Doroszkiewicz W.: Preliminary studies of the effect of ozone on the bactericidal properties of complement. Compl. Inflamm. 7, 57-62 (1990)
37. Jankowski S., Grzybek-Hryncewicz K.: Znaczenie bakteriobójczego działania dopełniacza w odporności na zakażenia bakteriami Gram-ujemnymi. Post. Med. Klin. Dośw. 4, 479-490 (1995)
38. Jann K., Jann B.: Bacterial polysaccharide antigens. (w:) Surface carbohydrates of the procaryotic cell. Ed.: Sutherland I. W., Academic Press, London. s. 247-297, 1977
39. Jarvis G.A., Verdos N.A.: Sialic acid of group B Neisseria meningitidis regulates of alternative complement pathway activation. Infect. Immun. 55, 174-177 (1987)
40. Jiang G.Z., Sugiyama T., Kato Y., Koide N., Yokochi T.: Binding of mannose-binding protein to Kliebsiella relation to complement activation. Infect. Immunol. 63, 2537-2540 (1995)
41. Johnson J.R.: Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4, 80-128 (1991)
42. Joiner K.A., Hammer C. H., Brown E.J., Cole R.J., Frank M.M.: Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited from Salmonella minnesota S218 without causing bacterial death. J. Exp. Med. 155, 797-804 (1982)
43. Kahler C.M., Martin L.E., Shih G.C., Rahman M.M., Carlson R.W., Stephens D.S.: The (L2→8) - linked polysialic acid capsule and lipopoligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect. Immun. 66, 5939-5947 (1998)
44. Katzenellenbogen E.: Badania strukturalne czȩśi cukrowej lipopolisacharydów Hafnia alvei. Post. Hig. Med. Dośw. 50, 431-445 (1996)
45. Kazatchkine M.D., Fearon D.T., Austen F.: Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b. J. Immunol. 122, 75-81 (1979)
46. Kȩdzierska B.: N-Acetylneuraminic acid: a constituent of the lipopolysaccharide of Salmonella toucra. Eur. J. Biochem. 91, 545-552 (1978)
47. Kirschfink M., Nurnberger W.: C1 inhibitor in anti inflammatory therapy: from animal experiment to clinical application. Molec. Immunol. 36, 225-232 (1999)
48. Klink M., Kaca W.: Aktywacja neutrofilów przez endotoksyny bakteryjne. Post. Hig. Med. Dośw. 50, 333-350 (1996)
49. Kraus D., Medof M.E., Mold C.: Complementary recognition of alternative pathway activators by decay-accelerating factor and factor H. Infect. Immun. 66, 339-405 (1998)
50. Kübler J., Mieszała M., Katzenellenbogen E., Gamian A., Romanowska E.: Charakterystyka strukturalna i serologiczna polisacharydó w O-swoistych Hafnia alvei PCM 1185 i 1199. Post. Hig. Med. Dośw. 50, 515-517 (1996)
51. Laich A., Sim R.B.: Interaction of the complement proteins C2 and C4. Molec. Immunol. Abstr. 36, 277-280 (1999)
52. Lambert P.A.: Enterobacteriaceae: composition, structure and function of the cell envelope. J. Appl. Bacteriol. (Suppl.) 21-34 (1988)
53. Lis H., Sharon N.: Protein glycosylation. Structural and functional aspects. Eur. J. Biochem. 218, 1-27 (1993)
54. Looney R.J., Steigbiegel R.T.: Role of the Vi antigen of Salmonella typhi in resistance to host defence in vitro. J. Lab. Clin. Med. 108, 506-510 (1986)
55. Lugtenberg B.: Composition and function of the outer membrane of E. coli. TIBS. 10, 262-266 (1981)
56. Mackinonn F.G., Gulati S., Gorringe P.A., Ram S.: The molecular basis of serum resistance in group B meningococci: inhibitor of membrane attack complex insertion by capsular polysaccharide. Molec. Immunol. Abstr. 36, 295-296 (1999)
57. Madsen H.O.: Genetics of mannose-binding lectin. Benzone Symposium: "Molecular Mechanisms of Innate Immunity", August 22-26. 25, Kopenhaga, Dania 1999
58. Markiewicz Z.: Struktura i funkcje osłon bakteryjnych. Wydawnictwo Naukowe PWN. Warszawa 1993
59. Matsushita M., Endo Y., Fuijta T.: MASP1 (MBL-associated serine protease 1). Immunobiol. 199, 340-347. (1998)
60. McCabe W.R., Kaijser B., Olling S., Uwaydah M., Hanson L. A.: Escherichia coli in bacteremia: K and O-antigens and serum sensitivity of strains from adults and neonates. J. Infect. Dis. 138, 33-37 (1978)
61. McGuire E.J., Binkley S.: The structure and chemistry of colominic acid. Biochemistry, 3, 247-251 (1964)
62. Mielnik G., Gamian A., Doroszkiewicz W.: Bactericidal activity of normal cord serum (NCS) against Gram-negative rods with sialic acid-containing lipopolysaccharides (LPS). FEMS Immnol. Med. Microbiol. 31, 169-173 (2001)
63. Mokracka-Latajka G., Jankowski S., Grzybek-Hryncewicz K., Krzyżanowska B.: The mechanism of bactericidal action of normal human serum against Salmonella rods. Acta Microbiol. Pol. 45, 169-180 (1996)
64. Morrison D.C., Danner R.L., Danavello C.A., Munford R.S., Natanson C., Pollack M., Spitzer J.J., Ulevitch R.J., Vogel S.N., Mc Sweegan E.: Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction. J. Endotx. Res. 1, 71-83 (1994)
65. Munn C.B., Ishiguro E.E., Kay W.W., Trust T.J.: Role of surface components in serum resistance of virulent Aeromonas salmonicida. Infect. Immun. 36, 1069-1075 (1982)
66. Nakae T.: Isolation of protein complex that produces transmembrane channels. J. Biol. Chem. 251, 2176-2178 (1976)
67. Nelson B.W., Roantree R.J.: Analysis of lipopolysaccharides extracted from penicillin-resistant, serum-sensitive Salmonella mutants. J. Gen. Microbiol. 48, 697-499 (1967)
68. Osborn M.J., Gander J.E., Parisi E., Carson J.: Mechanism of assembly of the outer membrane of Salmonella typhimurium. J. Biol. Chem. 247, 3962-3972 (1972)
69. Pasch M.C., Bos J.D., Daha M.R., Asghar S.S.: Transforming growth factor-isoforms regulated the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes. Eur. J. Immunol. 29, 100-108 (1999)
70. Pilz D., Vocke T., Heesemann J., Brade V.: Mechanism of Yad A-mediated serum resistance of Yersinia enterocolitica serotype O3. Infect. Immun. 60, 189-195 (1992)
71. Pluschke G., Achtman M.: Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O-antigen type and correlates with virulence of meningitis in newborns. Infect. Immun. 43, 684-686 (1984)
72. Ram S., Cullinane M., Blom A.M., Gulati S., McQuillen D.P., Monks B.G., O'Connel C., Boden R., Elkins Ch., Pangburn M.K., Dahlback B., Rice P.A.: Binding of C4b binding protein to porin A molecular mechanism of serum resistance of Neisseria gonorrhoeae. J. Exp. Med. 196, 281-295 (2001)
73. Ram S., Mackinnon F.G., Gulati S., McQuillen D.P., Vogel U., Frosch M., Elkins C., Guttormsen H.-K., Wetzer L.M., Oppermann M., Pangburnn M.K., Rice P.A.: The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Molec. Immunol. 36, 915-928 (1999)
74. Rautemaa R., Jarvis G.A., Marnila P., Meris S.: Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59). Infect. Immun. 66, 1928-1933 (1998)
75. Reeves P.: Role of O-antigen variation in the immune response. Trends in Microbiology, 3, 381-386 (1995)
76. Rietschel E.T., Brade L.: Bacterial endotoxins: properties and structures of biologically active domains. W: Surface structures of microorganisms and their interactions with the mammalian host (red.) Schrinner E., Richmont M.H., Seibert G., Schwarz U. Proceeding of the 18th workshop Conference Hoechst, Schloß Ringberg 1987, s. 1-41
77. Rietschel E.T., Kivikae T., Feist W., Loppnow H., Zabel P., Brade L., Ulmer A.J., Brade H., Seydel U., Zahringer U., Schlaak M., Flad M.D., Schade U.: Molecular aspects of the chemistry and biology of endotoxins. Molecular aspects of inflammation. Springer-Verlag 1991, s. 207-220
78. Roitt I., Brostoff J., Male D.: Immunologia. Wydawnictwo Lekarskie PZWL. 2000
79. Róźalski A.: Lipopolisacharyd (endotoksyna) - struktura chemiczna, a funkcje biologiczne. Przegla̧d najnowszych wiadomości. Post. Hig. Med. Dośw. 45, 315-333 (1991)
80. Rózalski A.: Lipopolisacharydy (LPS) bakterii Gram-ujemnych - struktura chemiczna, aktywność biologiczna i znaczenie w chorobotwórczości. II, Budowa chemiczna a funkcje biologiczne LPS. Post. Mikrobiol. 34, 317-337 (1995)
81. Rózalski A.: Lipopolisacharydy (LPS) bakterii Gram-ujemnych, struktura chemiczna, aktywność biologiczna i znaczenie w chorobotwórczości. III. Lipopolisacharyd jako czynnik chorobotwórczości bakterii Gram-ujemnych. Post. Mikrobiol. 34, 339-363 (1995)
82. Schauer R.: Sialic acids as antigenic determinants of complex carbohydrates. W: The Molecular Immunology of Complex Carbohydrates. red. Wu A.M., Adams L.G. Adv. Exp. Med. Biol. 228, 48-72 (1988)
83. Schiller N.L.: Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum sensitive strains. Infect. Immun. 56, 632-636 (1988)
84. Schultz D.R., Miller K.D.: Elastaze of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors. Infect. Immun. 10, 128-131 (1974)
85. Schweda E.K., Jonasson J.A., Jansson P.-E.: Structural studies of lipooligosaccharides from Haemophilus ducreyi ITM 5535, ITM 3147 and a fresh clinical isolate, ACY1: evidence for intrastrain heterogeneity with the production of mutally exclusive sialylated or elongated glycoforms. J. Bacteriol. 177, 5316-5321 (1995)
86. Spik G., Bayard B., Fournet B., Strecker G., Bouguelet S., Montreuil J.: Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett. 50, 296-299 (1975)
87. Stryer L.: Biochemia. Wyd. Nauk. PWN. Warszawa 1997, s. 508-511
88. Sundgvist G., Carlson J., Herrmann B., Tarnvik A.: Degradation of human immuglobulin G and M and complement factor C3 and C5 by black-pigmenteal Bacteroides. J. Med. Microbiol. 19, 85-86 (1985)
89. Taylor P.W.: Resistance of bacterial to complement. (w) Virulence mechanism of Bacterial Pathogens, 2nd ed., Ed. J.A. Roth et al. ASM Washington. D.C. s. 49-64, 1995
90. Taylor P.W., Kroll H.P.: Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli. Mol. Immunol. 21, 609-611 (1984)
91. Taylor P.W., Parton R.: A protein factor associated with serum resistance in Escherichia coli. J. Med. Microbiol. 10, 225-229 (1977)
92. 2-macroglobulin binds to and inhibits mannose-binding protein-associated serine protease. Inf. Immunol. 7, 1579-1584 (1995)
93. Tomas J.M., Ciurana B., Benedi V.J., Juarez A.: Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum. J. Gen. Microbiol. 134, 1009-1016 (1988)
94. Turner M.W.: Mannose-binding lectin in health and disease. Benzone Symposium: No. 46 "Molecular Mechanisms of Innate Immunity" August 22-26. Copenhagen. Denmark 1999
95. x adhezji i progresywnym wzroście nowotworowym. Post. Hig. Med. Dośw. 50, 209-231 (1996)
96. Van Dijk W. C., Verbrugh H. A., Peters R., Van de Tol M., Petersen P.K., Verhoef J.: Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis. J. Med. Microbiol. 12, 123-130 (1979)
97. Van Emmerik L.C., Kuijper E.J., Fijenc A.P., Dankert J., Thiel S.: Binding of mannan-binding protein to various bacterial pathogens of meningitidis. J. Exp. Immunol. 97, 411-416 (1994)
98. Wojnicz D., Jankowski S.: MBP-bialko wia̧ża̧ce mannozȩ i jego rola w odporności przeciwzakaźnej. Adv. Clin. Exp. Med. 9, 261-274 (2000)
99. Wojnicz D., Jankowski S.: Bialko CD59-charakterystyka i jego rola w ochronie komórek przed działaniem dopełniacza. Post. Mikrobiol. 69, 37-53 (2000)
100. Wright S.D., Ramos R.A., Tobias P.S., Ulevith R.J., Mathison J.C.: CD14, a receptor for complexes of lipopolysaccharides (LPS) and LPS binding protein. Science, 249, 1431-1433 (1990)